A DAILY pill that doubles survival time for lung cancer patients will be made routinely available on the NHS. Osimertinib, also known as Tagrisso and made by AstraZeneca, helps prevent cancer from ...
Hundreds of people are set to benefit from a daily pill that is going to be made routinely available on the NHS. The pill has shown to double survival time in certain lung cancer patients.
A daily pill that has shown to double survival time in certain lung cancer patients is to be made routinely available on the NHS, with hundreds of people set to benefit. Osimertinib, also known as ...